Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass

CompletedOBSERVATIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Breast CancerGenitourinary CancerMalignant Female Reproductive System NeoplasmMelanomaSarcoma
Interventions
PROCEDURE

Punch Biopsy

5 mm punch biopsy specimens from the affected, lymphedematous limb will be obtained just prior to lymphatico-venular bypass and six (6) months after lymphatico-venular bypass. Punch biopsies will be obtained from the radial (lateral) aspect of the upper arm approximately 10cm above the olecranon process. Biopsy specimens will be collected from the contralateral (normal) arm at the exact same location.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

M.D. Anderson Cancer Center

OTHER

NCT01433302 - Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass | Biotech Hunter | Biotech Hunter